Previous Article | Next Article ![]()
Journal of Clinical Microbiology, February 2007, p. 614-615, Vol. 45, No. 2
0095-1137/07/$08.00+0 doi:10.1128/JCM.01351-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
The University of Texas M.D. Anderson Cancer Center, Houston, Texas,1 JMI Laboratories, North Liberty, Iowa,2 Universidade Federal de Sao Paulo, Sao Paulo, Brazil,3 University of Bristol, Bristol, United Kingdom,4 Tufts University School of Medicine, Boston, Massachusetts5
Received 30 June 2006/ Returned for modification 26 August 2006/ Accepted 23 November 2006
Two Pseudomonas aeruginosa strains resistant to beta-lactams, fluoroquinolones, aminoglycosides, tetracyclines, and carbapenems and susceptible only to polymyxin B (MIC
2 µg/ml) were identified as part of the Meropenem Yearly Susceptibility Test Information Collection program. Metallo-ß-lactamase screening tests were positive, PCR yielded products with blaVIM primers, and sequence analysis revealed blaVIM-7 and blaVIM-2. The isolates had distinct ribotype and pulsed-field gel electorphoresis patterns and appeared independently, remote in time and location, at the same cancer center.
Published ahead of print on 6 December 2006.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»